Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank92
Studio
Year-over-Year Change

Free cash flow yield

Latest
-1.49%
↑ 97% vs avg
Percentile
P92
Near historical high
Streak
3 yr
Consecutive growthElevated
Average
-45.50%
Historical baseline
PeriodValueYoY Change
2025-1.49%+89.6%
2024-14.38%+78.6%
2023-67.31%+68.2%
2022-211.42%-1116.1%
2021-17.38%+8.8%
2020-19.06%+30.8%
2019-27.52%-31.6%
2018-20.91%+32.2%
2017-30.83%+31.1%
2016-44.73%-